Aptinyx (APTX) IPO Opens 9% Higher

Today's IPO for Aptinyx (NASDAQ: APTX) opened for trading at $17.40 after pricing 6,399,999 shares of its common stock at a public offering price of $16.00 per share.

In addition, Aptinyx has granted the underwriters a 30-day option to purchase 959,999 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.

J.P. Morgan, Cowen, Leerink Partners, and BMO Capital Markets are acting as joint book-runners for the offering.

Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.

You May Also Be Interested In

• CopperTech Metals launches IPO roadshow on NYSE at $16-$18 per share
• EG Group confidentially filed for $1 billion U.S. IPO - Bloomberg
• SpaceX bond sale draws $89 billion in investor demand